These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6877311)

  • 1. Incomplete labeling of pharmaceuticals: a list of "inactive" ingredients.
    Brown JL
    N Engl J Med; 1983 Aug; 309(7):439-41. PubMed ID: 6877311
    [No Abstract]   [Full Text] [Related]  

  • 2. Pitfalls of 'inert' ingredients.
    Millar JS
    Br J Gen Pract; 2001 Jul; 51(468):570. PubMed ID: 11462319
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactive ingredients listed in labeling.
    FDA Drug Bull; 1985 Dec; 15(4):39-40. PubMed ID: 4092906
    [No Abstract]   [Full Text] [Related]  

  • 4. What are excipients doing in medicinal products?
    Drug Ther Bull; 2009 Jul; 47(7):81-4. PubMed ID: 19567843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactive ingredients in medicines.
    Rippere V
    Lancet; 1988 Jul; 2(8604):224. PubMed ID: 2899701
    [No Abstract]   [Full Text] [Related]  

  • 6. "Passing off": a current legal issue in marketing of pharmaceuticals.
    Fink JL; Nelson AA
    Pharm Manage Comb Am J Pharm; 1979; 151(5):209-10. PubMed ID: 504375
    [No Abstract]   [Full Text] [Related]  

  • 7. "Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1997 Feb; 99(2):268-78. PubMed ID: 9024461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excipients: a hidden hazard.
    Gonzalo Garijo MA; Durán Quintana JA
    Allergol Immunopathol (Madr); 1996; 24(2):43. PubMed ID: 8933888
    [No Abstract]   [Full Text] [Related]  

  • 9. Excipients, adverse drug reactions and patients' rights.
    Napke E
    CMAJ; 1994 Sep; 151(5):529-33. PubMed ID: 8069798
    [No Abstract]   [Full Text] [Related]  

  • 10. The health hazard of unlabeled ingredients in pharmaceuticals.
    Brown JL
    Pediatrics; 1984 Mar; 73(3):402-4. PubMed ID: 6701067
    [No Abstract]   [Full Text] [Related]  

  • 11. The safety of pharmaceutical excipients.
    de Jong HJ
    Therapie; 1999; 54(1):11-4. PubMed ID: 10216416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary pharmaceuticals manufacturing.
    Burling JN; Shah PV
    Occup Med; 1997; 12(1):29-48. PubMed ID: 9153051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excipients and additives.
    Shear NH; Dupuis LL; Zimmerman B
    Can Med Assoc J; 1985 Jul; 133(2):93. PubMed ID: 4005766
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug labeling should be kept current.
    Rajpal A; Reidenberg MM
    Clin Pharmacol Ther; 2003 Jan; 73(1):4-6. PubMed ID: 12545138
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacy labeling practices; comments on pharmacy labeling methods.
    Cohen MR
    Hosp Pharm; 1993 Oct; 28(10):1038-40, 1043. PubMed ID: 10129139
    [No Abstract]   [Full Text] [Related]  

  • 17. Labeling information on nonprescription drug products.
    Am Pharm; 1988 Nov; NS28(11):24-5. PubMed ID: 3207092
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug safety labeling for doctors.
    Hecht A
    FDA Consum; 1979 Oct; 13(8):12-3. PubMed ID: 10309108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OTC labeling reform.
    J Am Pharm Assoc (Wash); 1997; NS37(6):619-20. PubMed ID: 9425787
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment and reporting of clinical pharmacology information in drug labeling.
    Spyker DA; Harvey ED; Harvey BE; Harvey AM; Rumack BH; Peck CC; Atkinson AJ; Woosley RL; Abernethy DR; Cantilena LR
    Clin Pharmacol Ther; 2000 Mar; 67(3):196-200. PubMed ID: 10741621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.